ロード中...
Elevated cutaneous Smad activation associates with enhanced skin tumor susceptibility in organ transplant recipients
PURPOSE: Non-melanoma skin cancer incidence is enhanced over fifty fold in patients taking anti-rejection drugs (ARDs) following organ transplantation. Pre-clinical studies suggest that ARD treatment increases transforming growth factor β1 (TGF-β1) levels, which contribute to enhanced tumor suscepti...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2009
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2812428/ https://ncbi.nlm.nih.gov/pubmed/19671862 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-08-3286 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|